A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes
To assess the efficacy and safety of DPP-4 inhibition with sitagliptin in youth with type 2 diabetes (T2D). Study Design This was a 54-week, double-blind, randomized, controlled clinical trial evaluating the safety and efficacy of DPP-4 inhibition with sitagliptin 100 mg once daily as initial oral t...
Saved in:
Main Authors: | Shankar, R. Ravi, Zeitler, Philip, Deeb, Asma, Jalaludin, Muhammad Yazid, Garcia, Raymundo, Newfield, Ron S., Samoilova, Yulia, Rosario, Carmen A., Shehadeh, Naim, Saha, Chandan K., Zhang, Yilong, Zilli, Martina, Scherer, Lynn W., Lam, Raymond L. H., Golm, Gregory T., Engel, Samuel S., Kaufman, Keith D. |
---|---|
Format: | Article |
Published: |
Wiley
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/33637/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin
by: Jalaludin, Muhammad Yazid, et al.
Published: (2022) -
Sitagliptin alters bone composition in high-fat-fed mice
by: Mansur, Sity Aishah, et al.
Published: (2018) -
Glycemic control in diabetic patients treated with
Sitagliptin in a single tertiary centre
by: WS, Wan Juani, et al.
Published: (2014) -
Information professional's competencies
by: Kaufman, Paula T.
Published: (2012) -
Direction and value of e-books: An academic perspective
by: Kaufman, Paula T.
Published: (2012)